Posizioni attive di Patrik Ernfors
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Glionova AB
 Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Direttore/Membro del Consiglio | 01/01/2014 | - |
| Fondatore | 01/01/2014 | - |
Storia della carriera di Patrik Ernfors
Precedenti posizioni note di Patrik Ernfors
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Direttore Tecnico/Scientifico/R&S | 01/09/2000 | - |
Statistiche
Distribuzione geografica
| Svezia | 3 |
Posizioni
| Chief Tech/Sci/R&D Officer | 1 |
| Director/Board Member | 1 |
| Founder | 1 |
Settori
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Global Genomics AB used to discovers disease genes, drug targets and disease-associated biomarkers. It was also developing and out-licenses proprietary tools in functional genomics that provide insight into healthy, diseased or drug-treated cells. The company was founded by Patrik Ernfors & Sten Linnarsson in September, 2000 and was located in Stockholm, Sweden. | Commercial Services |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Patrik Ernfors
- Esperienza
